Abbisko Therapeutics
company
About
Abbisko Therapeutics is a drug company dedicated to innovative drug research and development.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $28M
- Industries
- Health Care,Pharmaceutical,Therapeutics
- Founded date
- Apr 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Abbisko Therapeutics is a drug company dedicated to innovative drug research and development. The company is founded by a group of seasoned drug hunters with rich research and managerial experience in top pharmaceutical companies globally and in China.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$263M
Abbisko Therapeutics has raised a total of
$263M
in funding over 2 rounds. Their latest funding was raised on
Jan 7, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 7, 2021 | Series D | $123M | 1 | — | — | Detail |
| Mar 25, 2020 | Series C | $70M | 1 | — | — | Detail |
| Mar 21, 2019 | Series B | $42M | 1 | — | — | Detail |
| Feb 7, 2017 | Series A | $28M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Abbisko Therapeutics is funded by 1 investors.
Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Lilly Asia Ventures
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
